Dr. Joydeep Ghosh

Senior Consultant

17 Years of Experience

Medical Oncologist

MBBS, MD, DM

Reg. No.:2604, West Bengal Medical Council, 2007

Apollo Gleneagles Hospital, Kolkata

English

Consultation Fee ₹ 1000

Book an Appointment Contact with Doctor

Confirm Your Consultation With Dr. Joydeep Ghosh

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

About Dr. Joydeep Ghosh

Dr. Joydeep Ghosh is a highly skilled Medical Oncologist with 17 years of extensive experience.
He obtained his MBBS degree from Medical College and Hospital, Kolkata, in 2007.
Furthering his specialization, he pursued an MD in General Medicine from the Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital (IPGMER and SSKM hospital) in 2011.
Dr. Ghosh then pursued DM in Oncology from Tata Medical Center Mumbai in 2016, solidifying his specialization in oncology and cancer care.
His specialization includes treating breast cancer, gynecological cancers, and gastrointestinal cancers.
He is known for using the latest advancements in cancer treatment, such as hormone therapy, targeted therapy, and immunotherapy.
Devoted to providing high-quality care, Dr. Ghosh continually updates his knowledge and skills in oncology, a rapidly evolving field.
He is actively involved in research and academic pursuits, contributing to advancements in oncology and sharing his knowledge with the medical community through publications and presentations.
Patients trust Dr. Ghosh for his compassionate approach, extensive expertise, and commitment to delivering personalized care tailored to each individual's needs.
His professional affiliations and memberships include associations with prestigious medical societies, which reflect his dedication to staying current with the latest developments in oncology practice.

Confirm Your Consultation With Dr. Joydeep Ghosh

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MBBS - Medical College and Hospital, Kolkata - 2007
MD (Internal Medicine) - Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital (IPGMER and SSKM hospital) - 2011
DM (Medical Oncology) Tata Medical Center Mumbai - 2016

OPD Schedule Of Dr. Joydeep Ghosh

Book Appointment

Past Experience

Medical Consultant, TATA MEDICAL CENTER - 2023
DM Resident, TATA MEMORIAL HOSPITAL -2016
Senior Registrar, Apollo Hospitals - 2012
MD trainee, IPGMER and SSKM hospital - 2011

Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection?
Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India
Outcome of COVID-19 in Solid Organ Malignancies: Experience From a Tertiary Cancer Center in Eastern India
32P Clinical profile and presentation of patients with gastroenteropancreatic neuroendocrine neoplasms: An updated dataset from India
Real-world experience with maintenance PARPi plus minus Bevacizumab in newly diagnosed advanced ovarian cancer with Germline BRCA or HRD positive
Real-world study of safety and efficacy of lorlatinib as second line and beyond in ALK-rearranged advanced non-small cell lung cancer patients in India – a multicentre chart review study (ROSELAND)
EP156/#642 Survival outcomes in advanced stage operable carcinoma endometrium: experience of surgical treatment at a tertiary care cancer center
287MO Real-world experience with maintenance PARP inhibitor plus minus bevacizumab in newly diagnosed advanced ovarian cancer with germline BRCA mutations or homologous recombination deficiency (HRD) positive
Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) — Results from the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP) Study
272P Correlation of dihydropyrimidine dehydrogenase gene mutation with toxicity among gastrointestinal cancers (GI) taking 5-fluorouracil-based chemotherapy: Experience from a tertiary cancer center in the eastern part of India